Business UpdateApr 15, 2026, 04:21 PM
Transcode Therapeutics Reports $6.5M Non-Affiliate Market Value
AI Summary
Transcode Therapeutics, Inc. filed its annual report (Form 10-K) for the fiscal year ended December 31, 2025. The company reported an aggregate market value of approximately $6.5 million for its common stock held by non-affiliates as of June 30, 2025. The filing confirms the company's status as a non-accelerated filer, smaller reporting company, and emerging growth company.
Key Highlights
- Filed 2025 Annual Report (Form 10-K) for fiscal year ended December 31, 2025.
- Non-affiliate common stock market value was approximately $6.5 million as of June 30, 2025.
- Company is designated as a non-accelerated filer.
- Company is also a smaller reporting company and an emerging growth company.
Price Impact
More from RNAZ